Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
Published on: August 2, 2024
Neurotrophic Keratopathy in Herpes Zoster Ophthalmicus
1Department of Ophthalmology and Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Abstract:
Neurotrophic keratopathy (NK) is a serious condition that can lead to significant visual morbidity. One of the greatest challenges of treating NK is that there are a wide variety of underlying conditions that affect the corneal nerves, and the root cause of the NK for any given individual is necessary in order to provide the best possibility of treatment success. NK is noted to be frequently caused by herpetic disease, including herpes zoster ophthalmicus (HZO), and studies have demonstrated that the risk of developing NK increases with recurrences of HZO. As such, vaccination to prevent HZO, as well as suppressive valacyclovir to reduce the chance of multiple recurrences of HZO in individuals who have had HZO, can decrease the risk of NK from HZO as well as the subsequent vision loss. These preventative therapies are therefore highly recommended.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

